Ann: Appendix 4C - quarterly, page-11

There is often no sense regarding what the market does .
Basically the bulk of the market doesn't see any real potential with IMU ( YET )
Biotecs are traditionally risky , with most never actually achieving the "Holy Grail " of success . Hence I'm guessing the general lack lustre share price . ( But thats happening with a lot of small stocks right now any way )
Personally ( like lots of others here) I feel that IMU has massive potential , and this is supported be the quality of the scientific players on board . Just got to be patient .......there is the potential for this to be a 100 bagger long term in my view . ( Providing of course that the market is convinced of the potential & real effectiveness of their IP ) . Time will only tell on this front .
IF the IMU B Cell platform works and it can be seen to be effective in a very significant sense there will be an absolute scramble to buy the stock . The real question will be can IMU actually manage their growth and morph into a substantial business .

Cheers VA